Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway

<b>Background</b>: Pyroptosis, an inflammatory cell death, is involved in the progression of atherosclerosis. Pyroptosis in endothelial cells (ECs) and its underlying mechanisms in atherosclerosis are poorly understood. Here, we investigated the role of a caspase-4/5-NF-κB pathway in pyr...

Full description

Saved in:
Bibliographic Details
Main Authors: Salman Shamas, Razia Rashid Rahil, Laveena Kaushal, Vinod Kumar Sharma, Nissar Ahmad Wani, Shabir H. Qureshi, Sheikh F. Ahmad, Sabry M. Attia, Mohammad Afzal Zargar, Abid Hamid, Owais Mohmad Bhat
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/12/1568
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846103206391709696
author Salman Shamas
Razia Rashid Rahil
Laveena Kaushal
Vinod Kumar Sharma
Nissar Ahmad Wani
Shabir H. Qureshi
Sheikh F. Ahmad
Sabry M. Attia
Mohammad Afzal Zargar
Abid Hamid
Owais Mohmad Bhat
author_facet Salman Shamas
Razia Rashid Rahil
Laveena Kaushal
Vinod Kumar Sharma
Nissar Ahmad Wani
Shabir H. Qureshi
Sheikh F. Ahmad
Sabry M. Attia
Mohammad Afzal Zargar
Abid Hamid
Owais Mohmad Bhat
author_sort Salman Shamas
collection DOAJ
description <b>Background</b>: Pyroptosis, an inflammatory cell death, is involved in the progression of atherosclerosis. Pyroptosis in endothelial cells (ECs) and its underlying mechanisms in atherosclerosis are poorly understood. Here, we investigated the role of a caspase-4/5-NF-κB pathway in pyroptosis in palmitic acid (PA)-stimulated ECs and EVs as players in pyroptosis. <b>Methods</b>: Human umbilical vein endothelial cells (HUVECs) were cultured in an endothelial cell medium, treated with Ox-LDL, PA, caspase-4/5 inhibitor, NF-κB inhibitor, and sEV release inhibitor for 24 h, respectively. The cytotoxicity of PA was determined using an MTT assay, cell migration using a scratch-wound-healing assay, cell morphology using bright field microscopy, and lipid deposition using oil red O staining. The mRNA and protein expression of GSDM-D, CASP4, CASP5, NF-κB, NLRP3, IL-1β, and IL-18 were determined with RT-PCR and Western blot. Immunofluorescence was used to determine NLRP3 and ICAM-1 expressions. Extracellular vesicles (EVs) were isolated using an exosome isolation kit and were characterized by Western blot and scanning electron microscopy. <b>Results:</b> PA stimulation significantly changed the morphology of the HUVECs characterized by cell swelling, plasma membrane rupture, and increased LDH release, which are features of pyroptosis. PA significantly increased lipid accumulation and reduced cell migration. PA also triggered inflammation and endothelial dysfunction, as evidenced by NLRP3 activation, upregulation of ICAM-1 (endothelial activation marker), and pyroptotic markers (NLRP3, GSDM-D, IL-1β, IL-18). Inhibition of caspase-4/5 (Ac-FLTD-CMK) and NF-κB (trifluoroacetate salt (TFA)) resulted in a significant reduction in LDH release and expression of caspase-4/5, NF-κB, and gasdermin D (GSDM-D) in PA-treated HUVECs. Furthermore, GW4869, an exosome release inhibitor, markedly reduced LDH release in PA-stimulated HUVECs. EVs derived from PA-treated HUVECs exacerbated pyroptosis, as indicated by significantly increased LDH release and augmented expression of GSDM-D, NF-κB. <b>Conclusions:</b> The present study revealed that inflammatory, non-canonical caspase-4/5-NF-κB signaling may be one of the crucial mechanistic pathways associated with pyroptosis in ECs, and pyroptotic EVs facilitated pyroptosis in normal ECs during atherosclerosis.
format Article
id doaj-art-1aad42898094412582d7d654eb423292
institution Kabale University
issn 1424-8247
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-1aad42898094412582d7d654eb4232922024-12-27T14:45:43ZengMDPI AGPharmaceuticals1424-82472024-11-011712156810.3390/ph17121568Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D PathwaySalman Shamas0Razia Rashid Rahil1Laveena Kaushal2Vinod Kumar Sharma3Nissar Ahmad Wani4Shabir H. Qureshi5Sheikh F. Ahmad6Sabry M. Attia7Mohammad Afzal Zargar8Abid Hamid9Owais Mohmad Bhat10Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, IndiaDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, IndiaDepartment of Dermatology, Venereology & Leprology, Postgraduate Institute for Medical Education and Research, Chandigarh 160012, IndiaDepartment of Dermatology, Venereology & Leprology, Postgraduate Institute for Medical Education and Research, Chandigarh 160012, IndiaDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, IndiaDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, IndiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, IndiaDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, IndiaDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal 191201, India<b>Background</b>: Pyroptosis, an inflammatory cell death, is involved in the progression of atherosclerosis. Pyroptosis in endothelial cells (ECs) and its underlying mechanisms in atherosclerosis are poorly understood. Here, we investigated the role of a caspase-4/5-NF-κB pathway in pyroptosis in palmitic acid (PA)-stimulated ECs and EVs as players in pyroptosis. <b>Methods</b>: Human umbilical vein endothelial cells (HUVECs) were cultured in an endothelial cell medium, treated with Ox-LDL, PA, caspase-4/5 inhibitor, NF-κB inhibitor, and sEV release inhibitor for 24 h, respectively. The cytotoxicity of PA was determined using an MTT assay, cell migration using a scratch-wound-healing assay, cell morphology using bright field microscopy, and lipid deposition using oil red O staining. The mRNA and protein expression of GSDM-D, CASP4, CASP5, NF-κB, NLRP3, IL-1β, and IL-18 were determined with RT-PCR and Western blot. Immunofluorescence was used to determine NLRP3 and ICAM-1 expressions. Extracellular vesicles (EVs) were isolated using an exosome isolation kit and were characterized by Western blot and scanning electron microscopy. <b>Results:</b> PA stimulation significantly changed the morphology of the HUVECs characterized by cell swelling, plasma membrane rupture, and increased LDH release, which are features of pyroptosis. PA significantly increased lipid accumulation and reduced cell migration. PA also triggered inflammation and endothelial dysfunction, as evidenced by NLRP3 activation, upregulation of ICAM-1 (endothelial activation marker), and pyroptotic markers (NLRP3, GSDM-D, IL-1β, IL-18). Inhibition of caspase-4/5 (Ac-FLTD-CMK) and NF-κB (trifluoroacetate salt (TFA)) resulted in a significant reduction in LDH release and expression of caspase-4/5, NF-κB, and gasdermin D (GSDM-D) in PA-treated HUVECs. Furthermore, GW4869, an exosome release inhibitor, markedly reduced LDH release in PA-stimulated HUVECs. EVs derived from PA-treated HUVECs exacerbated pyroptosis, as indicated by significantly increased LDH release and augmented expression of GSDM-D, NF-κB. <b>Conclusions:</b> The present study revealed that inflammatory, non-canonical caspase-4/5-NF-κB signaling may be one of the crucial mechanistic pathways associated with pyroptosis in ECs, and pyroptotic EVs facilitated pyroptosis in normal ECs during atherosclerosis.https://www.mdpi.com/1424-8247/17/12/1568endothelial cellspyroptosisatherosclerosisinflammasomeendothelial dysfunctioninflammation
spellingShingle Salman Shamas
Razia Rashid Rahil
Laveena Kaushal
Vinod Kumar Sharma
Nissar Ahmad Wani
Shabir H. Qureshi
Sheikh F. Ahmad
Sabry M. Attia
Mohammad Afzal Zargar
Abid Hamid
Owais Mohmad Bhat
Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway
Pharmaceuticals
endothelial cells
pyroptosis
atherosclerosis
inflammasome
endothelial dysfunction
inflammation
title Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway
title_full Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway
title_fullStr Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway
title_full_unstemmed Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway
title_short Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway
title_sort pyroptosis in endothelial cells and extracellular vesicle release in atherosclerosis via nf κb caspase 4 5 gsdm d pathway
topic endothelial cells
pyroptosis
atherosclerosis
inflammasome
endothelial dysfunction
inflammation
url https://www.mdpi.com/1424-8247/17/12/1568
work_keys_str_mv AT salmanshamas pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT raziarashidrahil pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT laveenakaushal pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT vinodkumarsharma pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT nissarahmadwani pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT shabirhqureshi pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT sheikhfahmad pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT sabrymattia pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT mohammadafzalzargar pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT abidhamid pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway
AT owaismohmadbhat pyroptosisinendothelialcellsandextracellularvesiclereleaseinatherosclerosisvianfkbcaspase45gsdmdpathway